HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hani Bou Reslan Selected Research

Ligands

8/2012Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hani Bou Reslan Research Topics

Disease

5Neoplasms (Cancer)
07/2013 - 04/2008
4Neoplasm Metastasis (Metastasis)
08/2012 - 04/2008
1Prostatic Neoplasms (Prostate Cancer)
07/2013
1Breast Neoplasms (Breast Cancer)
11/2012
1Primitive Neuroectodermal Tumors (PNET)
08/2012
1Hypoxia (Hypoxemia)
08/2012
1Colorectal Neoplasms (Colorectal Cancer)
11/2009

Drug/Important Bio-Agent (IBA)

5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013 - 04/2008
1MTOR InhibitorsIBA
07/2013
1TOR Serine-Threonine KinasesIBA
07/2013
1GNE-317IBA
11/2012
1Proteins (Proteins, Gene)FDA Link
11/2012
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2012
1LigandsIBA
08/2012
1Sunitinib (Sutent)FDA Link
08/2012
1AntibodiesIBA
04/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2010
1Blocking AntibodiesIBA
04/2010
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2010
1Placenta Growth FactorIBA
04/2010
1Biomarkers (Surrogate Marker)IBA
11/2009
1Bevacizumab (Avastin)FDA Link
11/2009
1Neuropilin-2IBA
04/2008
1Vascular Endothelial Growth Factor CIBA
04/2008

Therapy/Procedure

2Therapeutics
08/2012 - 11/2009